September 27, 2021 – Page 14

Community Redevelopment Announces Plans For Full Service In-House Real Estate Brokerage

Written by Customer Service on September 27, 2021. Posted in Public Companies.

Full-service brokerage to open flagship office in South Florida MIAMI, Sept. 27, 2021 (GLOBE NEWSWIRE) — Community Redevelopment (OTC: CRDV) (“the Company”), a developer and owner of community oriented real estate in urban and suburban markets with a focus on all aspects of the real estate development cycle, announced today plans to open a full service, in-house real estate brokerage in the Miami Metropolitan Area with a commercial & residential division. The newly formed brokerage will specialize in residential sales and providing commercial real estate investment services to maximize value for clients. The mission of Community Redevelopment’s brokerage will be to ensure that the entire process of acquiring, selling, and leasing real estate is positive for all parties involved: Buyers, Sellers, and Realtors. Community...

Otonomy Announces Presentation of OTO-413 Clinical Results at AAO-HNS Annual Meeting

Written by Customer Service on September 27, 2021. Posted in Public Companies.

SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the presentation of previously disclosed clinical results from the successful OTO-413 Phase 1/2 trial at the upcoming American Academy of Otolaryngology – Head and Neck Surgery (AAO-HNS) Annual Meeting to be held in Los Angeles October 3-6, 2021. The oral presentation will be delivered on October 3, 2021 at 3:15 p.m. PT by Peter G. Volsky, M.D., Assistant Professor of Otology and Neurotology at Eastern Virginia Medical School. Dr. Volsky was an investigator in the trial during his prior clinical service with South Florida ENT Associates. “Difficulty understanding conversations in a noisy environment is a common complaint of patients presenting...

Intra-Cellular Therapies Announces Publication of Lumateperone Pivotal Phase 3 Study in Bipolar Depression in The American Journal of Psychiatry

Written by Customer Service on September 27, 2021. Posted in Public Companies.

In this study, lumateperone 42 mg showed significant reduction in depressive symptoms compared to placebo in patients with a major depressive episode associated with bipolar I or bipolar II disorder and a favorable safety and tolerability profile. These anti-depressant effects were statistically significant in both bipolar I and bipolar II disorder subgroup populations Consistent with prior studies, weight changes were similar to placebo with no notable changes in metabolic or prolactin levels. Incidence of extrapyramidal symptoms related events were low and similar to placebo These results, in conjunction with the positive results of Study 402 evaluating lumateperone 42 mg as adjunctive therapy with lithium or valproate, support lumateperone as a promising new treatment for patients with major depressive episodes associated with bipolar...

Ayr Wellness Adds to Florida Footprint with Opening of New Dispensary in Port Richey

Written by Customer Service on September 27, 2021. Posted in Public Companies.

MIAMI, Sept. 27, 2021 (GLOBE NEWSWIRE) — Ayr Wellness Inc. (CSE: AYR.A, OTC: AYRWF) (“Ayr” or the “Company”), a leading vertically integrated cannabis multi-state operator (“MSO”), today announced the opening of Liberty Health Sciences (LHS) Port Richey, the Company’s 42nd operating dispensary in Florida. The dispensary is located at 9314 US Highway 19, Port Richey, Florida, 34668 within Pasco County, which is home to a population of 560,000 people, according to the 2020 U.S. Census. The store brings LHS to the Gulf Coast city, which attracts visitors from throughout Florida and the U.S. for its lush landscapes and well-known 8,300-acre wilderness park. The new location features LHS’s expanded selection of flower strains, in addition to the Company’s recently launched Origyn concentrates, Big Pete’s Cookies and Secret Orchard vape...

Crinetics Pharmaceuticals to Unveil its Parathyroid Hormone Receptor Antagonist Program at the American Society for Bone and Mineral Research Annual Meeting

Written by Customer Service on September 27, 2021. Posted in Public Companies.

– Late-breaking Poster Presentation on Sunday, October 3, 2021 SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced its intent to develop a nonpeptide oral parathyroid hormone (PTH) receptor antagonist for the treatment of hypercalcemia associated with primary hyperparathyroidism (HPT) and other diseases of PTH receptor type 1 (PTHR1) over-activation. Details of the preclinical efforts supporting this newly disclosed program will be presented in a late-breaking poster at the upcoming annual meeting of the American Society for Bone and Mineral Research (ASBMR), which is being held October 1-4,...

Plus Therapeutics to Present at the Benzinga Healthcare Small Cap Conference

Written by Customer Service on September 27, 2021. Posted in Public Companies.

AUSTIN, Texas, Sept. 27, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today announced that Marc H. Hedrick M.D., President and Chief Executive Officer of Plus Therapeutics, will present a Company overview during the Benzinga Healthcare Small Cap Conference on Thursday, Septemeber 30, 2021 at 4:20 p.m. ET. Company management will also be available for one-on-one meetings throughout the conference. To access the presentation, please register at https://www.benzinga.com/events/small-cap/healthcare/. In addition, a replay of the presentation will be available under the ‘Events’ tab of the Investor Relations section of the Plus Therapeutics website at www.plustherapeutics.com. About...

iBio Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporate Update

Written by Customer Service on September 27, 2021. Posted in Earnings Releases And Operating Results.

Expanded Immuno-Oncology Pipeline with License of Next-Gen anti-CD25 Antibody for Solid Tumors Paired Access to RubrYc’s Antibody Discovery Platform with FastPharming® and GlycaneeringTM Platforms to Accelerate Drug Development Advanced COVID-19 Nucleocapsid-based Vaccine Candidate with pre-IND Submission BRYAN, Texas, Sept. 27, 2021 (GLOBE NEWSWIRE) — iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System®, today announced its financial results for the fiscal fourth quarter and year ended June 30, 2021. “Fiscal 2021 was a transformative period for iBio, highlighted by our entry into oncology and continued progress as a next-gen COVID-19 vaccine developer,” said Tom Isett, Chairman & CEO of iBio. “In...

Global Surgical Sutures Market Size to Reach USD 5.12 Billion 6% CAGR by 2028; Increasing Occurrence of Road Accidents to Propel Growth: Fortune Business Insights™

Written by Customer Service on September 27, 2021. Posted in Mergers And Acquisitions.

Key Prominent Players Covered in the Surgical Sutures Market Research Report Are Braun Melsungen AG, Johnson & Johnson Services, Inc., Smith & Nephew, Medtronic, Coloplast A/S, Apollo Endosurgery, Inc., Boston Scientific Corporation, DemeTECH Corporation, TEPHA INC., Internacional Farmacéutica, Kono Seisakusho Co., Ltd. Pune, India, Sept. 27, 2021 (GLOBE NEWSWIRE) — The global surgical sutures market size was USD 3.33 billion in 2020. The market is projected to grow from USD 3.41 billion in 2021 to USD 5.12 billion in 2028 at a CAGR of 6.0% in the 2021-2028 period. This information is published by Fortune Business Insights™ in its report titled, “Surgical Sutures Market, 2021-2028.” As per our researchers, the rising occurrence of road accidents and long-lasting diseases, occasioning in a greater percentage of patients...

Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting

Written by Customer Service on September 27, 2021. Posted in Public Companies.

Company to showcase key products at booth #1925 CARLSBAD, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it would be participating at the 2021 North American Spine Society (“NASS”) Annual Meeting, September 29-October 2, 2021 at the Boston Convention Center in Boston, Massachusetts at Booth #1925. The North American Spine Society is a global multidisciplinary medical society that utilizes education, research, and advocacy to foster the highest quality, ethical, value, and evidence-based spine care. Aurora Spine will showcase its new FDA-cleared DEXA-C anterior fusion cages used for cervical procedures...

Emerging Markets Report: EV’s and The Copper Castle

Written by Customer Service on September 27, 2021. Posted in Public Companies.

Intersection of Copper and Electric Vehicles Presents Opportunity for CAVU An Emerging Markets Sponsored Commentary ORLANDO, Fla., Sept. 27, 2021 (GLOBE NEWSWIRE) — In preparing today’s Emerging Markets report about CAVU Mining Corp. (CSE: CAVU) (OTC: CAVVF) (FSE: 8NQ), a mining company engaged in the acquisition, exploration and development of mineral projects containing metals used in green technologies and the renewable energy sector, we were pleased to see the Company’s clear focus on copper exploration. The reason is simple: copper is an essential material in the Electric Vehicle (EV) revolution. According to this detailed report from venerable Reuters, copper will have a significant role in the standardization of EV’s. It is often used as the wiring component of electric cars due to its superior conductivity. From the report: Electric...

Day: September 27, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice